A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
Clinical trial NCT02698566 · COMPLETED
Trial details
- NCT number
- NCT02698566
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2016-04-05
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.